中药在感染性疾病中的免疫调节作用综述
本文系统综述了中药、复方及其活性成分在感染性疾病中的免疫调节作用,桥接扶正祛邪理论与现代免疫学,涵盖固有免疫和适应性免疫的多条通路,并探讨其作为治疗剂和疫苗佐剂的潜力。
要点
- 中药复方可抑制NF-κB/MAPK通路,减少IL-6和TNF-α释放,缓解细胞因子风暴。
- 中药可调节巨噬细胞M1/M2极化平衡及Th1/Th2、Th17/Treg平衡。
- 部分中药复方具双向免疫调节作用,并可作为疫苗佐剂增强免疫原性。
核心结论
- 中药的多维免疫调节作用是其在感染性疾病中发挥疗效的关键机制之一。
- 本文有助于阐明中药复方及活性成分在感染性疾病防控中的多种免疫调节机制,并探讨其作为应对抗生素耐药和新发传染病等挑战的新策略来源的潜力。
研究设计与样本
- 在PubMed和CNKI等学术数据库中进行系统性文献检索,纳入英文和中文相关研究。
- 筛选聚焦于感染性疾病模型中使用中药复方或天然产物的研究,重点关注免疫相关结局。
主要发现
- 临床前和新兴临床证据提示,许多中药、复方及其活性成分通过调控关键免疫通路和分子靶点发挥多方面免疫调节作用,维持免疫稳态,具有前景但仍主要处于探索阶段的临床转化潜力。
- 固有免疫方面,部分中药复方可抑制NF-κB/MAPK等信号通路,减少IL-6和TNF-α等炎性细胞因子的过度释放,从而缓解感染诱导的细胞因子风暴。
- 部分中药及其活性成分可调节巨噬细胞M1/M2极化平衡,协同促进病原体清除和组织修复。
- 特定中药有助于恢复Th1/Th2和Th17/Treg平衡,减轻感染期间的过度炎症或免疫失调。
- 适应性免疫方面,特定中药复方和活性成分可上调树突状细胞上MHC-II和CD80/86等共刺激分子的表达,增强抗原提呈效率,促进病原体清除。
临床怎么用
- 在扶正祛邪理论指导下,中药及其复方的免疫调节作用为感染性疾病的临床防治提供了新视角和策略。
- 中药复方及活性成分可作为疫苗佐剂增强免疫原性,并参与感染后免疫重建。
局限性
- 证据主要来自临床前研究和新兴临床证据,临床转化潜力仍主要处于探索阶段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Infectious diseases remain a major global public health challenge. Traditional Chinese Medicine (TCM) embodies the medical wisdom of the Chinese nation, developed through thousands of years of practice in combating epidemics and infections. Guided by its unique theoretical system, centered on "Fuzheng Quxie" (Reinforcing Healthy qi and eliminating pathogenic factors, ), TCM approaches health and disease from a holistic and dialectical perspective, which differs fundamentally from conventional Western medicine. Its application reflects distinct ethnic medical characteristics rooted in Chinese philosophy and cosmology, and refined through long-term clinical observation. A growing body of evidence suggests that specific Chinese herbal medicines, traditional Chinese medicinal formulas and their active components exhibit various immunomodulatory properties. Nevertheless, a systematic analysis that considers these effects in the context of both traditional Chinese theory and modern immunology is still required. AIM OF THE REVIEW: This review aims to provide a comprehensive analysis of the immunomodulatory effects of specific Chinese herbal medicines, traditional Chinese medicinal formulas and their active components on infectious diseases. It seeks to bridge the underlying theory of these medicines with modern immunology and to evaluate their potential as therapeutic agents and vaccine adjuvants. MATERIALS AND METHODS: A systematic literature search was conducted in academic databases, including PubMed and CNKI, to identify relevant studies published in English and Chinese. Articles were selected based on their focus on TCM formulations or natural products used in infectious disease models, with an emphasis on immune-related outcomes. RESULTS: Preclinical and emerging clinical evidence suggests that many Chinese herbal medicines, traditional Chinese medicinal formulas and their active components exert multifaceted immunomodulatory effects by regulating key immune pathways and molecular targets, thereby maintaining the body's immune homeostasis and demonstrating promising, yet still largely exploratory, potential for clinical translation. In terms of innate immunity, some TCM formulas can inhibit signaling pathways such as NF-κB/MAPK, reducing the excessive release of inflammatory cytokines including IL-6 and TNF-α, thereby alleviating infection-induced cytokine storms. At the same time, some TCM and their active components can modulate the balance of macrophage M1/M2 polarization, synergistically promoting pathogen clearance and tissue repair. Furthermore, specific TCM helps restore the balance between Th1/Th2 and Th17/Treg, mitigating excessive inflammation or immune dysregulation during infection. In adaptive immunity, specific TCM formulas and active ingredients can upregulate the expression of MHC-II and co-stimulatory molecules such as CD80/86 on dendritic cells, enhancing antigen-presentation efficiency and thereby facilitating pathogen elimination. Some TCM formulas can also increase the CD4+/CD8+ T-cell ratio, promote the secretion of cytokines such as IL-2 and IFN-γ, and improve T-cell function by modulating immune checkpoint pathways such as PD-1/PD-L1. Meanwhile, specific TCM formulas stimulate B-lymphocyte proliferation and antibody class switching, promoting the production of IgM, IgA, and IgG and thereby enhancing humoral immune responses. Notably, some TCM formulations appear to exhibit bidirectional immunomodulatory properties. These properties suppress excessive inflammatory responses during infection while preserving certain aspects of adaptive immune function. This mechanism may contribute to the therapeutic effects of TCM in combating infections. Some TCM formulas and active ingredients also contribute to post-infection immune reconstruction and can act as a vaccine adjuvant to enhance immunogenicity. Guided by the TCM theory of "Fuzheng Quxie", the immunomodulatory role of TCM and its formulations in infection provide new perspectives and strategies for the clinical prevention and treatment of infectious diseases, holding important scientific exploration value and practical application prospects. CONCLUSIONS: The multidimensional immunomodulatory effects of TCM are one of the key mechanisms that make it effective against infections. This review helps clarify the multiple immunomodulatory mechanisms of some TCM formulas and their active components in the prevention and control of infectious diseases, and discusses its potential as a source of novel strategies for addressing major challenges such as antibiotic resistance and emerging infectious diseases.
引用
- Rao Z, Zhou H, Jing Q, et al. Immunomodulatory effect of traditional Chinese medicine in infectious diseases. J Ethnopharmacol. 2026. PMID: 42025778. doi:10.1016/j.jep.2026.121753
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。